Literature DB >> 22959227

Comprehensive approaches to managing delirium in patients with advanced cancer.

Jung Hun Kang1, Seong Hoon Shin, Eduardo Bruera.   

Abstract

Delirium is a frequently under-recognized complication in patients with advanced cancer. Uncontrolled delirium eventually leads to significant distress to patients and their families. However, delirium episodes can be reversed in half of these patients by eliminating precipitating factors and using appropriate interventions. The purpose of this narrative review is to discuss the most recent updates in the literature on the management of delirium in patients with advanced cancer. This article addresses the epidemiology, cause, pathophysiology, clinical characteristics, and assessment of delirium as well as various treatment options, including nonpharmacologic intervention and palliative sedation.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2012        PMID： 22959227      PMCID： PMC3881365          DOI： 10.1016/j.ctrv.2012.08.001

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


  91 in total

Review 1.  Microglia biology in health and disease.

Authors:  Gwenn A Garden; Thomas Möller
Journal:  J Neuroimmune Pharmacol       Date:  2006-03-25       Impact factor: 4.147

2.  Delirium as a disorder of consciousness.

Authors:  Ravi Bhat; Kenneth Rockwood
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-05-08       Impact factor: 10.154

3.  Evaluation of the memorial delirium assessment scale (MDAS) for the screening of delirium by means of simulated cases by palliative care health professionals.

Authors:  Nada Fadul; Guddi Kaur; Tao Zhang; J Lynn Palmer; Eduardo Bruera
Journal:  Support Care Cancer       Date:  2007-03-27       Impact factor: 3.603

4.  A new data-based motor subtype schema for delirium.

Authors:  David Meagher; Maria Moran; Bangaru Raju; Maeve Leonard; Sinead Donnelly; Jean Saunders; Paula Trzepacz
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2008       Impact factor: 2.198

Review 5.  Delirium phenomenology: what can we learn from the symptoms of delirium?

Authors:  Nitin Gupta; Jos de Jonghe; Jan Schieveld; Maeve Leonard; David Meagher
Journal:  J Psychosom Res       Date:  2008-09       Impact factor: 3.006

6.  Prevalence, detection and treatment of delirium in terminal cancer inpatients: a prospective survey.

Authors:  Chun-Kai Fang; Hong-Wen Chen; Shen-Ing Liu; Chen-Ju Lin; Li-Yun Tsai; Yuen-Liang Lai
Journal:  Jpn J Clin Oncol       Date:  2008-01-31       Impact factor: 3.019

7.  Clinical utility and use of DSM-IV and ICD-10 Criteria and The Memorial Delirium Assessment Scale in establishing a diagnosis of delirium after cardiac surgery.

Authors:  Jakub Kazmierski; Maciej Kowman; Maciej Banach; Wojciech Fendler; Piotr Okonski; Andrzej Banys; Ryszard Jaszewski; Tomasz Sobow; Iwona Kloszewska
Journal:  Psychosomatics       Date:  2008 Jan-Feb       Impact factor: 2.386

Review 8.  Delirium in cancer patients: a focus on treatment-induced psychopathology.

Authors:  Meera Agar; Peter Lawlor
Journal:  Curr Opin Oncol       Date:  2008-07       Impact factor: 3.645

9.  Opioid medications and longitudinal risk of delirium in hospitalized cancer patients.

Authors:  Jean-David Gaudreau; Pierre Gagnon; Marc-André Roy; François Harel; Annie Tremblay
Journal:  Cancer       Date:  2007-06-01       Impact factor: 6.860

Review 10.  Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence.

Authors:  Tammy T Hshieh; Tamara G Fong; Edward R Marcantonio; Sharon K Inouye
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-07       Impact factor: 6.053
View more
  6 in total

Review 1.  Clarifying delirium management: practical, evidenced-based, expert recommendations for clinical practice.

Authors:  Scott A Irwin; Rosene D Pirrello; Jeremy M Hirst; Gary T Buckholz; Frank D Ferris
Journal:  J Palliat Med       Date:  2013-03-12       Impact factor: 2.947

2.  Symptom expression in advanced cancer patients admitted to hospice or home care with and without delirium.

Authors:  Sebastiano Mercadante; Francesco Masedu; Marco Maltoni; Daniela De Giovanni; Luigi Montanari; Cristina Pittureri; Raffaella Bertè; Domenico Russo; Laura Ursini; Franco Marinangeli; Federica Aielli
Journal:  Intern Emerg Med       Date:  2018-10-17       Impact factor: 3.397

Review 3.  Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group.

Authors:  Samantha J Mayo; Maryam Lustberg; Haryana M Dhillon; Zev M Nakamura; Deborah H Allen; Diane Von Ah; Michelle C Janelsins; Alexandre Chan; Karin Olson; Chia Jie Tan; Yi Long Toh; Jeong Oh; Lisa Grech; Yin Ting Cheung; Ishwaria Mohan Subbiah; Duska Petranovic; James D'Olimpio; Margherita Gobbo; Susanne Koeppen; Charles L Loprinzi; Linda Pang; Shivani Shinde; Olanipekun Ntukidem; Katherine B Peters
Journal:  Support Care Cancer       Date:  2020-11-24       Impact factor: 3.603

4.  Frequency and Outcome of Neuroleptic Rotation in the Management of Delirium in Patients with Advanced Cancer.

Authors:  Seong Hoon Shin; David Hui; Gary Chisholm; Jung Hun Kang; Julio Allo; Janet Williams; Eduardo Bruera
Journal:  Cancer Res Treat       Date:  2014-11-24       Impact factor: 4.679

5.  Prevalence and risk factors of depressive symptoms in a Canadian palliative home care population: a cross-sectional study.

Authors:  Kathryn A Fisher; Hsien Seow; Kevin Brazil; Shannon Freeman; Trevor Frise Smith; Dawn M Guthrie
Journal:  BMC Palliat Care       Date:  2014-03-17       Impact factor: 3.234

6.  Intervention of Coordination by Liaison Nurse Where Ward Staff Struggled to Establish a Therapeutic Relationship with a Patient Because of Failure to Recognize Delirium: A Case Study.

Authors:  Yuri Nakai; Yusuke Nitta; Reiko Hashimoto
Journal:  Healthcare (Basel)       Date:  2022-07-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.